Axl ablation in macrophages can elicit the susceptibility of PD-1 refractory treatment naive B-ALL to PD-1 checkpoint blockade and promote antileukemia immunity (131). The gene discussed is PDCD1; the disease is acute lymphoblastic leukemia.